日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

针对TP53突变相关新抗原的双特异性抗体和CAR T细胞表现出不一致的亲和力要求。

DiNapoli Sarah R, Wright Katharine M, Mog Brian J, Pearlman Alexander H, Nichakawade Tushar D, Marcou Nikita, Hsiue Emily Han-Chung, Hwang Michael S, Douglass Jacqueline, Liu Qiang, Watson Evangeline, Dal Molin Marco, Cohen Joshua D, Popoli Maria, Paul Suman, Konig Maximilian F, Wyhs Nicolas, Azurmendi P Aitana, Glavaris Stephanie, Ge Jiaxin, Awosika Tolulope O, Liu Jin, Gabrielson Kathleen L, Gabelli Sandra B, Pardoll Drew M, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Zhou Shibin, Vogelstein Bert

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

PI3Kα抑制剂和降解剂Inavolisib可利用FGFR2增强PIK3CA突变实体瘤患者和临床前模型的疗效。

Juric Dejan, Song Kyung, Johnson Radia M, Accordino Melissa K, Bedard Philippe L, Cervantes Andrés, Gambardella Valentina, Hamilton Erika, Italiano Antoine, Kalinsky Kevin, Krop Ian E, Oliveira Mafalda, Saura Cristina, Schmid Peter, Turner Nicholas C, Varga Andreea, Gendreau Steven, Hwang Michael S, Kuang Zheng, Lau Jeffrey T, Lin Eva, Pham Trang, Maddalo Danilo, Rees Matthew G, Ronan Melissa M, Roth Jennifer A, Martin Scott, Sodir Nicole M, Sokol Ethan S, Whitfield Zachary J, Wong Alice, Yauch Robert L, Aimi Junko, Cheeti Sravanthi, Fredrickson Jill, Hilz Stephanie, Hafner Marc, Hutchinson Katherine E, Jin Yanling, Peters Ubong, Zingg Daniel, Royer-Joo Stephanie, Shankar Noopur, Schutzman Jennifer L, Jhaveri Komal L, Dey Anwesha

Lethal toxin-equipped effector cells for the potential treatment of cancer

携带致命毒素的效应细胞可用于癌症的潜在治疗

Pearlman, Alexander H; Mog, Brian J; Hwang, Michael S; Rincon-Torroella, Jordina; DiNapoli, Sarah R; Paul, Suman; Douglass, Jacqueline; Hsiue, Emily Han-Chung; Glavaris, Stephanie A; Pardoll, Drew M; Papadopoulos, Nickolas; Kinzler, Kenneth W; Bettegowda, Chetan; Zhou, Shibin; Vogelstein, Bert; Konig, Maximilian F

Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells

构建携带免疫毒素的效应细胞并在原代人免疫细胞中进行评估

Pearlman, Alexander H; Mog, Brian J; Hwang, Michael S; Rincon-Torroella, Jordina; DiNapoli, Sarah R; Paul, Suman; Douglass, Jacqueline; Hsiue, Emily Han-Chung; Glavaris, Stephanie A; Pardoll, Drew M; Papadopoulos, Nickolas; Kinzler, Kenneth W; Bettegowda, Chetan; Zhou, Shibin; Vogelstein, Bert; Konig, Maximilian F

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

临床前研究表明,Co-STARs 结合了嵌合抗原和 T 细胞受体的优势,可用于治疗抗原密度低的肿瘤

Mog Brian J, Marcou Nikita, DiNapoli Sarah R, Pearlman Alexander H, Nichakawade Tushar D, Hwang Michael S, Douglass Jacqueline, Hsiue Emily Han-Chung, Glavaris Stephanie, Wright Katharine M, Konig Maximilian F, Paul Suman, Wyhs Nicolas, Ge Jiaxin, Miller Michelle S, Azurmendi P, Watson Evangeline, Pardoll Drew M, Gabelli Sandra B, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Zhou Shibin

Targeting public neoantigens for cancer immunotherapy

靶向公共新抗原进行癌症免疫治疗

Pearlman, Alexander H; Hwang, Michael S; Konig, Maximilian F; Hsiue, Emily Han-Chung; Douglass, Jacqueline; DiNapoli, Sarah R; Mog, Brian J; Bettegowda, Chetan; Pardoll, Drew M; Gabelli, Sandra B; Papadopoulos, Nicholas; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin

Author Correction: Targeting public neoantigens for cancer immunotherapy

作者更正:靶向公共新抗原进行癌症免疫治疗

Pearlman, Alexander H; Hwang, Michael S; Konig, Maximilian F; Hsiue, Emily Han-Chung; Douglass, Jacqueline; DiNapoli, Sarah R; Mog, Brian J; Bettegowda, Chetan; Pardoll, Drew M; Gabelli, Sandra B; Papadopoulos, Nicholas; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin

Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes

产生针对体细胞突变基因编码的HLA限制性表位的MANA抗体

Skora, Andrew D; Douglass, Jacqueline; Hwang, Michael S; Tam, Ada J; Blosser, Richard L; Gabelli, Sandra B; Cao, Jianhong; Diaz, Luis A Jr; Papadopoulos, Nickolas; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases

前列腺癌的转移进展以及zeb1和SRC家族激酶对E-钙黏蛋白的调控

Putzke, Aaron P; Ventura, Aviva P; Bailey, Alexander M; Akture, Canan; Opoku-Ansah, John; Celiktaş, Müge; Hwang, Michael S; Darling, Douglas S; Coleman, Ilsa M; Nelson, Peter S; Nguyen, Holly M; Corey, Eva; Tewari, Muneesh; Morrissey, Colm; Vessella, Robert L; Knudsen, Beatrice S